Overview
Vibrio vulnificus is a Gram-negative bacterium causing severe infections including primary sepsis, traumatic wound infections, and gastroenteritis, often acquired through seafood consumption or water exposure. It can lead to rapid progression with multi-organ dysfunction and may necessitate amputation or surgical intervention 1.Diagnosis
Clinical Presentation: Rapid onset of symptoms such as fever, chills, and signs of sepsis or necrotizing fasciitis 1.
Laboratory Tests: Elevated white blood cell count, thrombocytopenia, and elevated inflammatory markers 1.
Culture and Sensitivity: Isolation of V. vulnificus from blood, wound, or stool cultures; sensitivity testing crucial for guiding antibiotic therapy 1.
Imaging: Imaging may show soft tissue swelling or gas formation indicative of necrotizing fasciitis 1.Management
Antibiotics: Initial empirical therapy with broad-spectrum antibiotics (e.g., carbapenems, third-generation cephalosporins) followed by targeted therapy based on sensitivity results (e.g., doxycycline, ceftazidime, aminoglycosides) 1.
Surgical Intervention: Early surgical debridement for necrotizing fasciitis and severe wound infections 1.
Supportive Care: Intensive care support including fluid resuscitation, vasopressors for shock, and organ support for MODS 1.Special Populations
Elderly and Comorbidities: Increased susceptibility to severe outcomes; careful monitoring and aggressive management are essential 1.
Pediatrics: Limited data; similar aggressive approach as adults but tailored to pediatric dosing and physiology 1.
Pregnancy: No specific data provided; management should focus on maternal and fetal safety with close monitoring 1.Key Recommendations
Initiate broad-spectrum antibiotics immediately upon suspicion of Vibrio vulnificus infection and tailor based on culture sensitivity results (Evidence: Moderate 1).
Perform early surgical debridement for patients with necrotizing fasciitis to improve outcomes (Evidence: Moderate 1).
Closely monitor and manage organ dysfunction syndromes with appropriate intensive care support (Evidence: Moderate 1).References
1 Leng F, Lin S, Wu W, Zhang J, Song J, Zhong M. Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2019. link